Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII)
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2020 ◽
2019 ◽
2019 ◽
